Neil Chatterji
Stock Analyst at B. Riley Securities
(2.59)
# 2,290
Out of 5,026 analysts
19
Total ratings
41.18%
Success rate
23.73%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $24.62 | +13.73% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $19.80 | -34.34% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $45.80 | +9.17% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.76 | +326.14% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $20.80 | -13.46% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $3.96 | +13.64% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.39 | +151.80% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $3.05 | +80.33% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $2.20 | +332.80% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $24.62
Upside: +13.73%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $19.80
Upside: -34.34%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $45.80
Upside: +9.17%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.76
Upside: +326.14%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $20.80
Upside: -13.46%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.96
Upside: +13.64%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.39
Upside: +151.80%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $3.05
Upside: +80.33%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $2.20
Upside: +332.80%